RNS Number : 6821Z
JPMorgan Emerging EMEA Securities
06 March 2025
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC ('the Company' or 'JEMA')

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

 

Withdrawal of Two AGM Resolutions

 

The Board of JPMorgan Emerging Europe, Middle East & Africa Securities plc (JEMA), announces that it has decided to withdraw Resolutions 9. and 10. from the Agenda of the Company's Annual General Meeting ("AGM"), to be held at 60 Victoria Embankment, London EC4Y 0JP on 7th March 2025 at 2.00p.m.

 

Resolution 9. and Resolution 10. proposed to authorise the Company's Directors to allot new shares and disapply preemption rights respectively. The Board proposed these two resolutions as they considered that the authorities would have provided flexibility that were in the interests of the Company. Both resolutions have historically been included in the Company's AGM and approved with significant votes in favour, although the authorities provided to the Directors have never been previously exercised. However, some shareholders have expressed concerns about Resolutions 9. and 10.  proposed at the Company's 7th March 2025 AGM. Although the Board have reiterated to the shareholders expressing concern that there are no plans to allot new shares, given the concerns of some shareholders which were also reflected in the figures for the provisional proxy votes received ahead of the AGM, the Board have decided to withdraw Resolutions 9. and 10. from the Company's 7th March 2025 AGM.

 

The above decision does not affect the other resolutions proposed in the Notice of the 7th March 2025 AGM and the meeting will proceed as previously notified.   

 

 

6th March 2025

 

For further information:

 

Paul Winship, Neil Martin, JPMorgan Funds Limited             0800 20 40 20

Hugh Jonathan, Deutsche Numis                                           020 7260 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLFVSIRIIE